{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:46:39Z","timestamp":1766515599357},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,23]]},"DOI":"10.7759\/cureus.44001","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T23:19:35Z","timestamp":1692832775000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Cholestatic Liver Involvement Secondary to Amyloid Light Chain Amyloidosis With New-Onset Hypercholesterolemia and Elevated Gamma-Glutamyltransferase Level"],"prefix":"10.7759","author":[{"given":"Yuta","family":"Nakano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisaku","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayoko","family":"Matukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy291","article-title":"AL amyloidosis: advances in diagnostics and treatment","volume":"34","author":"Ry\u0161av\u00e1 R","year":"2019","unstructured":"Ry\u0161av\u00e1 R. AL amyloidosis: advances in diagnostics and treatment. Nephrol Dial Transplant. 2019, 34:1460-6. 10.1093\/ndt\/gfy291","journal-title":"Nephrol Dial Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2018.05.004","article-title":"Management of the elderly patient with AL amyloidosis","volume":"58","author":"Nuvolone M","year":"2018","unstructured":"Nuvolone M, Milani P, Palladini G, Merlini G. Management of the elderly patient with AL amyloidosis. Eur J Intern Med. 2018, 58:48-56. 10.1016\/j.ejim.2018.05.004","journal-title":"Eur J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.9.1322","article-title":"Primary amyloidosis and severe intrahepatic cholestatic jaundice","volume":"35","author":"Peters RA","year":"1994","unstructured":"Peters RA, Koukoulis G, Gimson A, Portmann B, Westaby D, Williams R. Primary amyloidosis and severe intrahepatic cholestatic jaundice. Gut. 1994, 35:1322-5. 10.1136\/gut.35.9.1322","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-54","article-title":"Al amyloidosis","volume":"7","author":"Desport E","year":"2012","unstructured":"Desport E, Bridoux F, Sirac C, et al.. Al amyloidosis. Orphanet J Rare Dis. 2012, 7:54. 10.1186\/1750-1172-7-54","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00529-w","article-title":"Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study","volume":"11","author":"Staron A","year":"2021","unstructured":"Staron A, Zheng L, Doros G, Connors LH, Mendelson LM, Joshi T, Sanchorawala V. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021, 11:139. 10.1038\/s41408-021-00529-w","journal-title":"Blood Cancer J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-013-0406-x","article-title":"A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?","volume":"6","author":"Takao S","year":"2013","unstructured":"Takao S, Tanaka K, Miyazaki M, et al.. A case of fatal intrahepatic cholestasis with primary AL amyloidosis: is early diagnosis possible?. Clin J Gastroenterol. 2013, 6:386-9. 10.1007\/s12328-013-0406-x","journal-title":"Clin J Gastroenterol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000091183.93122.c7","article-title":"Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients","volume":"82","author":"Park MA","year":"2003","unstructured":"Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore). 2003, 82:291-8. 10.1097\/01.md.0000091183.93122.c7","journal-title":"Medicine (Baltimore)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90505-0","article-title":"Hepatic amyloidosis (Primary [AL], immunoglobulin light chain): the natural history in 80 patients","volume":"85","author":"Gertz MA","year":"1988","unstructured":"Gertz MA, Kyle RA. Hepatic amyloidosis (Primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med. 1988, 85:73-80. 10.1016\/0002-9343(88)90505-0","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.106226","article-title":"Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement","volume":"86","author":"Zhang LL","year":"2019","unstructured":"Zhang LL, Shen KN, Zhang CL, et al.. Clinical presentation and prognostic analysis of Chinese patients with systemic light chain amyloidosis with liver involvement. Leuk Res. 2019, 86:106226. 10.1016\/j.leukres.2019.106226","journal-title":"Leuk Res"},{"key":"ref10","article-title":"Hyperlipidemia as the first biochemical manifestation of primary hepatic amyloidosis","volume":"92","author":"Couture P","year":"1997","unstructured":"Couture P, LeBlanc F, Gagnon P, Gagnon O, Gagn\u00e9 C. Hyperlipidemia as the first biochemical manifestation of primary hepatic amyloidosis. Am J Gastroenterol. 1997, 92:1046-7.","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13738","article-title":"Diagnostic considerations for cholestatic liver disease","volume":"32","author":"Pollock G","year":"2017","unstructured":"Pollock G, Minuk GY. Diagnostic considerations for cholestatic liver disease. J Gastroenterol Hepatol. 2017, 32:1303-9. 10.1111\/jgh.13738","journal-title":"J Gastroenterol Hepatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-020-01825-2","article-title":"The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey","volume":"21","author":"Al-Zahrani J","year":"2021","unstructured":"Al-Zahrani J, Shubair MM, Al-Ghamdi S, et al.. The prevalence of hypercholesterolemia and associated risk factors in Al-Kharj population, Saudi Arabia: a cross-sectional survey. BMC Cardiovasc Disord. 2021, 21:22. 10.1186\/s12872-020-01825-2","journal-title":"BMC Cardiovasc Disord"},{"key":"ref13","article-title":"Hypercholesterolemia","author":"Ibrahim MA","year":"2022","unstructured":"Ibrahim MA, Asuka E, Jialal I. Hypercholesterolemia. StatPearls [Internet], Treasure Island (FL); 2022."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-101124","article-title":"Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy","volume":"10","author":"Wah-Suarez MI","year":"2019","unstructured":"Wah-Suarez MI, Danford CJ, Patwardhan VR, Jiang ZG, Bonder A. Hyperlipidaemia in primary biliary cholangitis: treatment, safety and efficacy. Frontline Gastroenterol. 2019, 10:401-8. 10.1136\/flgastro-2018-101124","journal-title":"Frontline Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0390-3","article-title":"Diagnosis and management of primary biliary cholangitis","volume":"114","author":"Younossi ZM","year":"2019","unstructured":"Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. Diagnosis and management of primary biliary cholangitis. Am J Gastroenterol. 2019, 114:48-63. 10.1038\/s41395-018-0390-3","journal-title":"Am J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01028-8","article-title":"Updates in cardiac amyloidosis diagnosis and treatment","volume":"23","author":"Stern LK","year":"2021","unstructured":"Stern LK, Kittleson MM. Updates in cardiac amyloidosis diagnosis and treatment. Curr Oncol Rep. 2021, 23:47. 10.1007\/s11912-021-01028-8","journal-title":"Curr Oncol Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar S","year":"2012","unstructured":"Kumar S, Dispenzieri A, Lacy MQ, et al.. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol. 2012, 30:989-95. 10.1200\/JCO.2011.38.5724","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12617","article-title":"Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis","volume":"281","author":"Muchtar E","year":"2017","unstructured":"Muchtar E, Dean DS, Dispenzieri A, et al.. Prevalence and predictors of thyroid functional abnormalities in newly diagnosed AL amyloidosis. J Intern Med. 2017, 281:611-9. 10.1111\/joim.12617","journal-title":"J Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.22959","article-title":"Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival","volume":"56","author":"Prokaeva T","year":"2007","unstructured":"Prokaeva T, Spencer B, Kaut M, et al.. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum. 2007, 56:3858-68. 10.1002\/art.22959","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/178628-a-case-of-cholestatic-liver-involvement-secondary-to-amyloid-light-chain-amyloidosis-with-new-onset-hypercholesterolemia-and-elevated-gamma-glutamyltransferase-level","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:18Z","timestamp":1707508518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/178628-a-case-of-cholestatic-liver-involvement-secondary-to-amyloid-light-chain-amyloidosis-with-new-onset-hypercholesterolemia-and-elevated-gamma-glutamyltransferase-level"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.44001","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,23]]}}}